Literatur
Beyer-Westendorf J, Pannach S (2013) Increase of gastrointestinal bleeding with new oral anticoagulants: problems of a meta-analysis. Gastroenterology 145: 1162–1163
Brouwer MA, Jaspers Focks J, Verheugt FW (2013) Novel antithrombotic challenges: head, heart, and guts. Gastroenterology 145: 1163–1164
Desai J, Granger CB, Weitz JI et al (2013) Novel oral anticoagulants in gastroenterology practice. Gastrointest Endosc 78: 227–239
Heidbuchel H, Verhamme P, Alings M et al (2013) European heart rhythm association practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation. Europace 15: 625–651
Pernod G, Albaladejo P, Godier A et al (2013) Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP) – March 2013. Arch Cardiovas Dis 106: 382–393
Einhaltung ethischer Richtlinien
Interessenkonflikt. Der Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Arlt, A. Risiken der neuen oralen Antikoagulanzien. Gastroenterologe 9, 48–49 (2014). https://doi.org/10.1007/s11377-013-0831-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11377-013-0831-x